Globus Medical (GMED)

Operating profit margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Operating income (ttm) US$ in thousands 214,623 164,471 116,777 118,864 133,142 177,047 236,345 237,909 227,951 192,123 185,750 163,850 171,953 212,288 208,972 137,533 111,433 102,878 94,926 163,358
Revenue (ttm) US$ in thousands 2,519,355 2,478,596 2,236,530 1,898,454 1,568,476 1,226,440 1,096,949 1,068,982 1,022,843 998,366 973,939 961,307 958,102 941,526 927,903 825,809 789,042 767,264 747,381 792,998
Operating profit margin 8.52% 6.64% 5.22% 6.26% 8.49% 14.44% 21.55% 22.26% 22.29% 19.24% 19.07% 17.04% 17.95% 22.55% 22.52% 16.65% 14.12% 13.41% 12.70% 20.60%

December 31, 2024 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $214,623K ÷ $2,519,355K
= 8.52%

The operating profit margin for Globus Medical fluctuated over the period from March 31, 2020, to December 31, 2024. It started at 20.60% in March 2020 and experienced some variations, reaching a low of 5.22% in June 2024. The margin generally exhibited a downward trend from June 2023 to December 2024, indicating potentially increasing costs relative to revenue. However, there were spikes in the margin in June 2021, September 2021, and December 2022, where it exceeded 20%. The latest data point, December 31, 2024, shows a slight recovery in the operating profit margin to 8.52%. Overall, the analysis suggests that Globus Medical has faced challenges in maintaining a consistent level of operating profitability in recent periods.